252 related articles for article (PubMed ID: 32184801)
41. Overexpressed SNRPB/D1/D3/E/F/G correlate with poor survival and immune infiltration in hepatocellular carcinoma.
Li FP; Liu GH; Zhang XQ; Kong WJ; Mei J; Wang M; Dai YH
Am J Transl Res; 2022; 14(6):4207-4228. PubMed ID: 35836882
[TBL] [Abstract][Full Text] [Related]
42. CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Xie XW; Jiang SS; Li X
Front Mol Biosci; 2020; 7():614034. PubMed ID: 33553242
[TBL] [Abstract][Full Text] [Related]
43. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
44. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
45. [Expression of transcription factor SOX12 in lung adenocarcinoma and its clinical significance].
Li L; Zhang T; Chen Y; Song J; Meng Y; Liu S; Xie J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):186-191. PubMed ID: 30890507
[TBL] [Abstract][Full Text] [Related]
46. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
47. Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Deng Z; Huang K; Liu D; Luo N; Liu T; Han L; Du D; Lian D; Zhong Z; Peng J
J Hepatocell Carcinoma; 2021; 8():1607-1622. PubMed ID: 34956967
[TBL] [Abstract][Full Text] [Related]
48. The upregulation of
Cui Z; Wang J; Chen G; Li D; Cheng B; Lai Y; Wu Z
Front Oncol; 2022; 12():1081510. PubMed ID: 36698420
[TBL] [Abstract][Full Text] [Related]
49. Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties.
Vu NB; Nguyen TT; Tran LC; Do CD; Nguyen BH; Phan NK; Pham PV
Cytotechnology; 2013 Aug; 65(4):491-503. PubMed ID: 23104270
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.
Zhao Q; Zhou H; Liu Q; Cao Y; Wang G; Hu A; Ruan L; Wang S; Bo Q; Chen W; Hu C; Xu D; Tao F; Cao J; Ge Y; Yu Z; Li L; Wang H
Oncotarget; 2016 Jul; 7(30):47431-47443. PubMed ID: 27329727
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
Li J; Hu K; He D; Zhou L; Wang Z; Tao Y
Front Oncol; 2020; 10():604131. PubMed ID: 33489909
[TBL] [Abstract][Full Text] [Related]
52. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma.
Che Y; Wang G; Xia Q
Front Genet; 2022; 13():937310. PubMed ID: 36105112
[No Abstract] [Full Text] [Related]
53. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
54. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
55. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
56. The expression of
Zhang X; Zheng Y; Liu X; Wang K; Zhao H; Yin Y; Yu Y
Ann Transl Med; 2022 Jan; 10(2):81. PubMed ID: 35282072
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma.
Liu Y; Li R; Wang X; Xue Z; Yang X; Tang B
Front Cell Dev Biol; 2022; 10():824938. PubMed ID: 35693941
[No Abstract] [Full Text] [Related]
58. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma.
Sun L; Yu S; Dong C; Wu Z; Huang H; Chen Z; Wu Z; Yin X
Front Genet; 2022; 13():913398. PubMed ID: 35928441
[No Abstract] [Full Text] [Related]
59. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
60. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
